Volta Labs Automates Twist’s Full Hybrid Capture Portfolio on Callisto
BOSTON, June 12, 2026 Volta Labs, a leader in genomics workflow automation, has announced the launch of Twist Bioscience’s...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BOSTON, June 12, 2026 Volta Labs, a leader in genomics workflow automation, has announced the launch of Twist Bioscience’s...
MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...
NEW YORK, April 23, 2026 Biotia announced the publication of a pivotal clinical validation study in the Microbiology Spectrum...
